Drug General Information (ID: DDI7KDM5IC)
  Drug Name Leuprolide Drug Info Capromab pendetide Drug Info
  Drug Type Small molecule Monoclonal antibody
  Therapeutic Class Antineoplastics Diagnostic Agents
  Structure

 Mechanism of Leuprolide-Capromab pendetide Interaction (Severity Level: Moderate)
     Attenuated pharmacological effects (Unspecific) Click to Show/Hide Mechanism Graph
      Drug Name Leuprolide Capromab pendetide
      Mechanism Interfere with the imaging performance of Indium In 111 capromab pendetide due to the increased expression of PSMA Indium In 111 capromab pendetide
      Key Mechanism Factor 1
Factor Name Pharmacodynamics
Factor Description Reduced pharmacological effects leading to insufficient efficacy and/or treatment failure.
      Mechanism Description
  • Attenuated pharmacological effects of  Capromab pendetide when combined with Leuprolide 

Recommended Action
      Management Until more data are available, concomitant use of Indium In 111 capromab pendetide in patients treated with androgen ablation therapy is not recommended.

References
1 Product Information. ProstaScint (capromab pendetide). Aytu BioScience, Inc, Englewood, CO.